MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Parkinsonian syndrome prevalence in the world

F. Gulyamova (Tashkent, Uzbekistan)

Meeting: 2016 International Congress

Abstract Number: 452

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Epidemiology

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To analyze the static data in the incidence of Parkinson’s disease in the world.

Background: Parkinson’s disease is considered a progressive multisystem disorder involving dopaminergic, noradrenergic, serotoninergic and cholinergic systems, characterized by motor and non-motor (autonomic, sleep, sensory and neuropsychiatric) systems. These symptoms may presede motor manifestation. The recognition of these symptoms in the premotor phase of the disease is important to early diagnosis and treatment.

Methods: Statistics and epidemiological analysis of the data.

Results: This is a characteristic age-dependent pathology. So, with a total prevalence of Parkinson’s diseases in the range of 150-300 per 100 thousand. Population incidence increases significantly in older age groups. In the group over 65 years there has been 1700 cases per 100 thousand population (Walters EC, 2007). It is estimated that every tenth patient Parkinson’s diseases begins before 50 years, every twentieth – up to 40 years. In connection with this release a special subgroup – Parkinson’s diseases with early onset at age debut in the range of 21 to 40 years. The term "youthful (juvenile)" Parkinson’s is used when symptoms appear up to 20 years.

Conclusions: PD is the disease of the brain which requires a long-term treat¬ment and the number of its’ patients have ranked third place in the world after di¬abetes. It is very difficult to get the accurate numbers of Parkinson’s diseases dissemination due to unavailability of a single registry as well as the fact that Parkinson’s diseases is often intentionally or mistakenly not diagnosed or passes under the dif¬ferent diagnoses (related and movement disorders), which are not taken into the overall statistics of Parkinson’s diseases.

To cite this abstract in AMA style:

F. Gulyamova. Parkinsonian syndrome prevalence in the world [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/parkinsonian-syndrome-prevalence-in-the-world/. Accessed June 14, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/parkinsonian-syndrome-prevalence-in-the-world/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Humor processing is affected by Parkinson’s disease and levodopa
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley